An AIHA relapse followed in April 2022, with Hb at 9.5 g/dL, LDH two‐fold above the reference range and elevated reticulocyte count (Figure 1A, Table S2). This evidence concerns the gene GSTM1 and autoimmune hemolytic anemia.